NVZMY:OTCMKTS
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
$69.42
arrow_upward
+0.26%(+0.18) 1D
$69.42
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 20, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVZMY...
Open
$69.49
High
$70.29
Low
$69.02
Mkt. cap
191.40B
Avg. vol.
23.66K
Volume
0.00
52-wk high
$75.26
52-wk low
$49.90
Beta
0.87
Shares outstanding
414.56M
No. of employees
11K
Open
$69.49
High
$70.29
Low
$69.02
Mkt. cap
191.40B
Avg. vol.
23.66K
Volume
0.00
52-wk high
$75.26
52-wk low
$49.90
Beta
0.87
Shares outstanding
414.56M
No. of employees
11K
News stories
From web sources and news partners
ad-hoc-news.de
·
17 hours ago
Novonesis reports buyback transactions as Novonesis stock trades at EUR 62.00
www.marketscreener.com
·
1 day ago
Transactions under Novonesis’ share buyback program
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, Greater Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About NOVONESIS NOVOZYMES B Unsponsored Denmark ADR